Scientific Advisory Board and Stakeholder Group
The Scientific Advisory Board (SAB) will be set up at the beginning of the project aiming to:
- Provide feedback on the project results and assessing the match between the outcomes and expected impacts,
- Contribute to reach considerable visibility of the project results at the EU level. The SAB is already composed at this stage, confirming the interest of members listed in the table below to be part of the project. Additional members will be contacted before the project launch.
The Stakeholder Group (SG) will be set up at the beginning of the project. The objective is to :
- Support the consortium by bringing in expertise from a range of stakeholders
- Get feedback on the impact of the project’s results on local economies and specific stakeholder groups.
These external experts will not have decision-making power and will sign an NDA. The SAB and SG will meet at least 3 times during the project: at M19, M34 and M59, tentatively.
The EMINENCE proposal is supported by the Cameroon Minister of Public Health, who provided an official endorsement letter.
Scientific Advisory Board
Dr. Adrian Hopkins
Expert on onchocerciasis elimination. Former Director of The Mectizan Donation Program. Independent consultant in neglected and disabling diseases of poverty. Has in- depth knowledge of field-based clinical studies and the issues and difficulties concerning onchocerciasis elimination. UK
Prof. Roger Moyou-Somo
Expert in tropical medicine, parasitology, and onchocerciasis epidemiology. Based at Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaoundé, Cameroon.
Dr. Amy Klion
Immuno-parasitologist, expert in filarial infections generally and onchocerciasis in particular. She has vast experience in Loa trials with albendazole, ivermectin and diethylcarbamazine. Based at the National Institute of Allergy and Infectious Diseases, USA.
Stakeholder Group
Dr. Maria Rebollo Polo
Lead of Global Programme for Elimination of Onchocerciasis, World Health Organization, Geneva, Switzerland.
Dr. Laura Senyonjo
Senior NTD Epidemiologist and Surveillance Advisor, Sightsavers, Haywards Heath, UK.
Prof. Charles Mackenzie
Expert on onchocerciasis, loiasis and lymphatic filariasis. Has ample experience in post-ivermectin loiasis-related adverse events. Task Force for Global Health, Atlanta, USA.
About Us
The EMINENCE project is dedicated to eliminating onchocerciasis in Africa through innovative clinical research and the evaluation of moxidectin to enhance disease control and accelerate eradication efforts.
Useful Links:
Social Media
© EMINENCE - EDCTP. All rights reserved